Key Peripheral Nerve Stimulators Market Players:
- Braun SE
- Company Overview
- Business Strategy
- Key Product Offerings
- Financial Performance
- Key Performance Indicators
- Risk Analysis
- Recent Development
- Regional Presence
- SWOT Analysis
- Boston Scientific Corporation
- Curonix LLC
- SPR Therapeutics
- AVNS
- Teleflex Incorporated
- SUNMED
- Xavant Technology (Pty) Ltd
- Neuspera Medical
- Vygon
- Medtronic
Key companies in the peripheral nerve stimulators market are driving innovation through advancements in technology, such as wireless, implantable, and programmable devices that enhance patient comfort and treatment efficacy. For instance, in June 2024, Nalu Medical announced key findings from a clinical trial evaluating the Nalu peripheral nerve stimulation system for treating chronic pain. Companies are developing compact, cost-effective PNS solutions with improved customization, integrating AI and remote monitoring to make therapy more accessible and personalized for chronic pain patients. These key players include:
Browse key industry insights with market data tables & charts from the report:
Frequently Asked Questions (FAQ)
In the year 2026, the industry size of peripheral nerve stimulators is assessed at USD 688.04 million.
Peripheral Nerve Stimulators Market size was over USD 656.71 million in 2025 and is anticipated to cross USD 1.1 billion by 2035, growing at more than 5.3% CAGR during the forecast period i.e., between 2026-2035.
North America commands the Peripheral Nerve Stimulators Market with a 39.2% share, driven by the opioid crisis and adoption of safer pain management solutions, enhancing growth prospects through 2026–2035.
Key players in the market include SPR Therapeutics, AVNS, Teleflex Incorporated.
